TELEFLEX INC (TFX): debt financing — Teleflex increases delayed draw term loan facility by $200M to $700M for Vascular Intervention acquisition

TELEFLEX INC

Amendment to Credit Agreement added $200M in delayed draw term loans, bringing total commitments to $700M.
Funds available upon consummation of the acquisition of MS Holding II SE's Vascular Intervention business.
Amendment dated June 24, 2025, with JPMorgan Chase Bank as administrative agent and several lenders.
No material changes to other terms of the credit agreement beyond the commitment increase.

item 1.01 item 2.03 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

TELEFLEX INC incurred term loan of $200,000,000.

Instrument: term loan
Principal: $200,000,000
Event: incurrence

Exact text from the filing

which provides for additional delayed draw term loan commitments that are of the same class as the delayed draw term loan commitments outstanding under the Existing Credit Agreement immediately prior to giving effect to the Amendment (such existing commitments, the "Existing Delayed Draw Term Loan Commitments"), in an aggregate principal amount of $200,000,000

View on SEC.gov

Browse all debt financings →

TELEFLEX INC filing history →

Source: SEC EDGAR

accession 0000096943-25-000107

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.